Proteome Sciences (LON:PRM) Trading Down 16.7% – Should You Sell?

by · The Cerbat Gem

Proteome Sciences plc (LON:PRM – Get Free Report)’s stock price was down 16.7% on Thursday . The company traded as low as GBX 2.30 ($0.03) and last traded at GBX 2.30 ($0.03). Approximately 288,265 shares were traded during trading, an increase of 81% from the average daily volume of 159,581 shares. The stock had previously closed at GBX 2.76 ($0.04).

Proteome Sciences Trading Down 5.1 %

The firm has a market capitalization of £7.73 million, a PE ratio of -262.00 and a beta of 0.07. The firm has a 50 day simple moving average of GBX 3.01 and a 200 day simple moving average of GBX 3.38.

About Proteome Sciences

(Get Free Report)

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.

Read More